Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
SPECIAL ANNOUNCEMENT
2016 Photonics Buyers' Guide Clearance! – Use Coupon Code FC16 to save 60%!
share
Email Facebook Twitter Google+ LinkedIn Comments

Daily News Briefs

Photonics.com
Aug 2003
Royal Philips Electronics of the Netherlands has established several new research collaborations through its new molecular imaging (MI) business unit, which is in the process of setting up an MI user group and a scientific advisory board. Under a three-year National Cancer Institute contract, Philips is collaborating with Washington University, Dow Chemical and Kereos to develop target-specific nantotechnology molecular agents. The company has also begun a collaborative research project with Washington University and Kereos to develop a targeted contrast agent for computed tomography (CT), and is working with the Theseus Imaging subsidiary of North American Scientific Inc. to optimize the methodology for in vivo imaging of cardiac cell death. Philips showcased its MI technologies at the 2nd annual meeting of the Society for Molecular Imaging (SMI) last week in San Francisco. In June, Phillips introduced MOSAIC, an advanced "small bore" animal positron emission tomography (PET) imaging system. It also announced an exclusive worldwide distribution agreement with ImTek Inc., of Knoxville, Tenn., for ImTek's MicroCAT II in-vivo x-ray CT scanner, also for use in animal research.


Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top

Facebook Twitter Instagram LinkedIn YouTube RSS
©2016 Photonics Media
x We deliver – right to your inbox. Subscribe FREE to our newsletters.